Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

Established in 1994, this innovative R&D and manufacturing company focuses on the pharmaceutical and health sectors. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards, operating sophisticated drug production facilities that meet cGMP specifications from regulatory bodies such as NMPA, FDA, and EMA. The company's diverse portfolio includes biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs), with over 300 product approvals across various categories. Its products are distributed in more than 40 countries and regions, including Singapore, South Korea, Italy, and China.